The global Cell and Gene Therapy Manufacturing Market is witnessing exponential growth, with market value estimated at USD 39.76 billion in 2026 and projected to reach USD 336.25 billion by 2036, growing at a CAGR of 23.8% during the forecast period. Increasing adoption of personalized medicine, expanding clinical pipelines for gene and cell therapies, and rising investments in viral...
SPARK Website
English